-
Trends in syphilis, gonorrhoea and chlamydia: a descriptive analysis of national surveillance data, Poland, 2013 to 2024
-
View Affiliations Hide AffiliationsCorrespondence:Damian Kadylakdamian.kadylak gumed.edu.pl
-
View Citation Hide Citation
Citation style for this article: . Trends in syphilis, gonorrhoea and chlamydia: a descriptive analysis of national surveillance data, Poland, 2013 to 2024. Euro Surveill. 2026;31(28):pii=2500916. https://doi.org/10.2807/1560-7917.ES.2026.31.28.2500916 Received: 04 Dec 2025; Accepted: 31 Mar 2026
Abstract
While bacterial sexually transmitted infections (STIs) have increased across Europe over the past decade, Poland continuously reported the lowest notification rates in the European Union/European Economic Area (EU/EEA), raising concerns about under-ascertainment and diagnostic gaps.
We describe national STI trends in Poland from 2013 to 2024, temporal changes around 2020 and subsequent years, and demographic and geographic patterns relevant for STI control.
We analysed aggregated statutory surveillance data for syphilis, gonorrhoea and Chlamydia trachomatis infections, and calculated annual incidence rates overall and by sex, age group and voivodeship. Temporal trends were assessed using year-over-year per cent change and average annual per cent change (AAPC) estimated from log-linear models.
All three infections increased modestly before 2020, declined in 2020 and increased markedly thereafter. Between 2013 and 2024, incidence increased 2.7–3.8-fold. It was highest among men, young adults aged 20–34 years and in urbanised regions. By 2023, syphilis incidence reached 7.92 per 100,000 population in Poland compared with 9.9 per 100,000 in the EU/EEA, whereas gonorrhoea and chlamydia incidence remained substantially lower. National AAPC estimates were not statistically significant, although they increased in several demographic groups and voivodeships.
Reported bacterial STI notifications in Poland are increasing, particularly among young adults and in urban regions. Persistently low gonorrhoea and chlamydia notification rates relative to EU/EEA levels probably reflect differences in diagnostic access and testing intensity rather than low transmission. Improving surveillance completeness, access to NAAT diagnostics, and testing coverage will be important to enhance detection and control.
Full text loading...


